NIH launches clinical trials network to test COVID-19 vaccines
Singapore, July 9 -- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health in the US, has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.
The COVID-19 Prevention Trials Network (COVPN) was established by merging four existing NIAID-funded clinical trials networks: the HIV Vaccine Trials Network (HVTN), based in Seattle; the HIV Prevention Trials Network (HPTN), based in Durham, N.C.; the Infectious Diseases Clinical Research Consortium (IDCRC), based in Atlanta; and the AIDS Clinical Trials Group, based ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.